Sponsor pipeline

Cell Origin Biotech (Hangzhou) Co., Ltd. clinical trial pipeline

Get alerts when Cell Origin Biotech (Hangzhou) Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Not applicable
NCT06562647 SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With… Treatment Related Cancer Recruiting 2026-02-13

Disease areas by active trials

Ovarian Cancer (1)

Get alerts when Cell Origin Biotech (Hangzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free